Ovintiv Inc. (OVV)

Negative revenue growth while AR stands at 9.28%. Joel Greenblatt would look for strategic missteps or cyclical reasons.

EBIT growth below 50% of AR's 169.46%. Michael Burry would suspect deeper competitive or cost structure issues.

Operating income growth under 50% of AR's 169.46%. Michael Burry would be concerned about deeper cost or sales issues.

Negative net income growth while AR stands at 197.55%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while AR is at 193.59%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while AR is at 193.59%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

Negative 10Y revenue/share CAGR while AR stands at 333.21%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.

Negative 3Y CAGR while AR stands at 333.21%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

Negative 10Y OCF/share CAGR while AR stands at 82.93%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.

Negative 5Y OCF/share CAGR while AR is at 82.93%. Joel Greenblatt would question the firm’s operational model or cost structure.

Negative 3Y OCF/share CAGR while AR stands at 82.93%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.

Negative 10Y net income/share CAGR while AR is at 8555.46%. Joel Greenblatt sees a major red flag in long-term profit erosion.

Negative 5Y net income/share CAGR while AR is 8555.46%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.

Below 50% of AR's 8555.46%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.

Below 50% of AR's 156.79%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.

Negative 5Y equity/share growth while AR is at 156.79%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.

Negative 3Y equity/share growth while AR is at 156.79%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.

Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.

Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.

AR growth well above AR's 46.02%. Michael Burry fears inflated revenue or higher default risk in the near future.

Asset growth at 50-75% of AR's 24.23%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.

Under 50% of AR's 44.13%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.

Debt growth far above AR's 5.43%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.